The ones I have been to have been pretty fun. It's a good way to meet people in person. I'm not associated with them. I just think it's a good event.
To register call (Phone number can only be seen by myHIVteam users) or online at LifeGroupLA.org/register.
Researchers have provided new insight into the cellular processes behind the 'shock and kill' approach to curing HIV, which they say challenges the effectiveness of the treatment. Their study, published in the journal eLife, suggests the need to explore alternative treatment strategies against HIV -- a virus which 36.7 million people globally were living with in 2016, with 1.8 million people becoming newly infected in the same year, according to figures from UNAIDS.… read more
An HIV-positive man transmitted HIV to his sexual partner after interrupting antiretroviral therapy as part of a research study into a therapeutic vaccine, French scientists reported in the Journal of Infectious Diseases last week. The case report underlines the importance of participants in cure and vaccine studies being made aware of this potential and of prescribing pre-exposure prophylaxis (PrEP) to their sexual partners.
The 59 year-old man had been diagnosed… read more
This article exceeds the 3000 character cap on this page, by the web designers for myHIVteam - but here is the link to read all about this exciting news from the Scripps Research Institure:
Infectious disease specialist, molecular epidemiologist and is the director of the Institute of Molecular Biology and Biotechnology at the National Institutes of Health at the University of the Philippines in Manila.
This site limits detail characters to 3000 - so I will just post the link for you to read.
I hope this discovery helps lead science closer to a cure.
A structural model of viperin a naturally occurring enzyme in humans that is known to have antiviral effects on viruses such as West Nile, hepatitis C, rabies, and HIV. A new study led by researchers from Penn State and the Albert Einstein College of Medicine reveals the… read more
HIV-positive smokers metabolise nicotine at a significantly higher rate than HIV-negative individuals, investigators from the United States report in the online edition of AIDS. The finding could explain why people with HIV have more difficulty quitting smoking than their HIV-negative peers. A second study involving the same HIV-positive smokers and published in the Journal of Acquired Immune Deficiency Syndromes showed that a higher nicotine… read more
DATE: August 27, 2018
Immune activation and inflammation persist in the majority of treated HIV-infected individuals and is associated with excess risk of mortality and morbidity. A new study by Boston University School of Medicine (BUSM) researchers suggests that use of HIV RNA expression inhibitors as adjunct therapy might diminish atypical inflammation and restore immune function in HIV-infected individuals… read more
This site limits details to 3000 characters. So, I will just post a link to some important relevations about the greedy intentions of Mylan with respect to HIV Generics.
Read and know thy enemy.
We never share your personal information with anyone.Continue with Facebook Sign up with your email